Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery
PAR4_HUMAN Reviewed; 385 AA.
Q96RI0; O76067; Q6DK42;
27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
17-OCT-2006, sequence version 3.
23-FEB-2022, entry version 177.
RecName: Full=Proteinase-activated receptor 4;
Short=PAR-4;
AltName: Full=Coagulation factor II receptor-like 3;
AltName: Full=Thrombin receptor-like 3;
Flags: Precursor;
Name=F2RL3; Synonyms=PAR4;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-120.
PubMed=9722561; DOI=10.1074/jbc.273.36.23290;
Kahn M.L., Hammes S.R., Botka C., Coughlin S.R.;
"Gene and locus structure and chromosomal localization of the protease-
activated receptor gene family.";
J. Biol. Chem. 273:23290-23296(1998).
[2]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-120.
PubMed=9716134; DOI=10.1038/29325;
Kahn M.L., Zheng Y.-W., Huang W., Bigornia V., Zeng D., Moff S.,
Farese R.V. Jr., Tam C., Coughlin S.R.;
"A dual thrombin receptor system for platelet activation.";
Nature 394:690-694(1998).
[3]
NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF ARG-47 AND ARG-68, AND VARIANT
THR-120.
TISSUE=Lymphoma;
PubMed=9618465; DOI=10.1073/pnas.95.12.6642;
Xu W.-F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A.,
Gilbert T., Davie E.W., Foster D.C.;
"Cloning and characterization of human protease-activated receptor 4.";
Proc. Natl. Acad. Sci. U.S.A. 95:6642-6646(1998).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lung;
King M.M., Aronstam R.S., Sharma S.V.;
"cDNA clones of human proteins involved in signal transduction sequenced by
the Guthrie cDNA resource center (www.cdna.org).";
Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-296 AND LEU-310.
SeattleSNPs variation discovery resource;
Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project:
the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
FUNCTION.
PubMed=10079109; DOI=10.1172/jci6042;
Kahn M.L., Nakanishi-Matsui M., Shapiro M.J., Ishihara H., Coughlin S.R.;
"Protease-activated receptors 1 and 4 mediate activation of human platelets
by thrombin.";
J. Clin. Invest. 103:879-887(1999).
-!- FUNCTION: Receptor for activated thrombin or trypsin coupled to G
proteins that stimulate phosphoinositide hydrolysis. May play a role in
platelets activation. {ECO:0000269|PubMed:10079109}.
-!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
-!- TISSUE SPECIFICITY: Widely expressed, with highest levels in lung,
pancreas, thyroid, testis and small intestine. Not expressed in brain,
kidney, spinal cord and peripheral blood leukocytes. Also detected in
platelets.
-!- PTM: A proteolytic cleavage generates a new N-terminus that functions
as a tethered ligand.
-!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
{ECO:0000255|PROSITE-ProRule:PRU00521}.
-!- WEB RESOURCE: Name=SeattleSNPs;
URL="http://pga.gs.washington.edu/data/f2rl3/";
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; AF080214; AAC28860.1; -; mRNA.
EMBL; AF055917; AAC25699.1; -; mRNA.
EMBL; AY431102; AAR08487.1; -; mRNA.
EMBL; AF384819; AAK61908.1; -; Genomic_DNA.
EMBL; BC074782; AAH74782.2; -; mRNA.
CCDS; CCDS12350.1; -.
RefSeq; NP_003941.2; NM_003950.3.
PDB; 2ZPK; X-ray; 1.80 A; P/Q=46-53.
PDB; 3QDZ; X-ray; 2.80 A; E/F=39-47.
PDBsum; 2ZPK; -.
PDBsum; 3QDZ; -.
SMR; Q96RI0; -.
BioGRID; 114481; 3.
ELM; Q96RI0; -.
STRING; 9606.ENSP00000248076; -.
BindingDB; Q96RI0; -.
ChEMBL; CHEMBL4691; -.
DrugBank; DB11300; Thrombin.
GuidetoPHARMACOLOGY; 350; -.
GlyGen; Q96RI0; 1 site.
iPTMnet; Q96RI0; -.
PhosphoSitePlus; Q96RI0; -.
BioMuta; F2RL3; -.
DMDM; 116242700; -.
jPOST; Q96RI0; -.
MassIVE; Q96RI0; -.
PaxDb; Q96RI0; -.
PeptideAtlas; Q96RI0; -.
PRIDE; Q96RI0; -.
ProteomicsDB; 77962; -.
ABCD; Q96RI0; 2 sequenced antibodies.
Antibodypedia; 14245; 405 antibodies from 33 providers.
DNASU; 9002; -.
Ensembl; ENST00000248076; ENSP00000248076; ENSG00000127533.
GeneID; 9002; -.
KEGG; hsa:9002; -.
MANE-Select; ENST00000248076.4; ENSP00000248076.2; NM_003950.4; NP_003941.2.
UCSC; uc002nfa.4; human.
CTD; 9002; -.
DisGeNET; 9002; -.
GeneCards; F2RL3; -.
HGNC; HGNC:3540; F2RL3.
HPA; ENSG00000127533; Tissue enhanced (adipose tissue, lung, thyroid gland).
MIM; 602779; gene.
neXtProt; NX_Q96RI0; -.
OpenTargets; ENSG00000127533; -.
PharmGKB; PA27949; -.
VEuPathDB; HostDB:ENSG00000127533; -.
eggNOG; ENOG502QU4Y; Eukaryota.
GeneTree; ENSGT00970000193405; -.
HOGENOM; CLU_009579_8_2_1; -.
InParanoid; Q96RI0; -.
OMA; GMGTHSS; -.
OrthoDB; 995441at2759; -.
PhylomeDB; Q96RI0; -.
TreeFam; TF350010; -.
PathwayCommons; Q96RI0; -.
Reactome; R-HSA-375276; Peptide ligand-binding receptors.
Reactome; R-HSA-416476; G alpha (q) signalling events.
Reactome; R-HSA-456926; Thrombin signalling through proteinase activated receptors (PARs).
SignaLink; Q96RI0; -.
SIGNOR; Q96RI0; -.
BioGRID-ORCS; 9002; 5 hits in 1043 CRISPR screens.
EvolutionaryTrace; Q96RI0; -.
GeneWiki; F2RL3; -.
GenomeRNAi; 9002; -.
Pharos; Q96RI0; Tchem.
PRO; PR:Q96RI0; -.
Proteomes; UP000005640; Chromosome 19.
RNAct; Q96RI0; protein.
Bgee; ENSG00000127533; Expressed in adipose tissue and 102 other tissues.
ExpressionAtlas; Q96RI0; baseline and differential.
GO; GO:0005576; C:extracellular region; TAS:Reactome.
GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
GO; GO:0005886; C:plasma membrane; IDA:HPA.
GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
GO; GO:0015057; F:thrombin-activated receptor activity; TAS:ProtInc.
GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; TAS:ProtInc.
GO; GO:0030168; P:platelet activation; IDA:UniProtKB.
GO; GO:0060155; P:platelet dense granule organization; IC:BHF-UCL.
GO; GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; IBA:GO_Central.
GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IBA:GO_Central.
GO; GO:0009611; P:response to wounding; TAS:ProtInc.
GO; GO:0007165; P:signal transduction; TAS:ProtInc.
InterPro; IPR000276; GPCR_Rhodpsn.
InterPro; IPR017452; GPCR_Rhodpsn_7TM.
InterPro; IPR003944; Prot_act_rcpt_4.
InterPro; IPR003912; Protea_act_rcpt.
Pfam; PF00001; 7tm_1; 1.
PRINTS; PR00237; GPCRRHODOPSN.
PRINTS; PR01428; PROTEASEAR.
PRINTS; PR01430; PROTEASEAR4.
PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
1: Evidence at protein level;
3D-structure; Blood coagulation; Cell membrane; Disulfide bond;
G-protein coupled receptor; Glycoprotein; Hemostasis; Membrane; Receptor;
Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix.
SIGNAL 1..17
/evidence="ECO:0000255"
PROPEP 18..47
/note="Removed for receptor activation"
/evidence="ECO:0000250"
/id="PRO_0000012762"
CHAIN 48..385
/note="Proteinase-activated receptor 4"
/id="PRO_0000012763"
TOPO_DOM 48..82
/note="Extracellular"
/evidence="ECO:0000255"
TRANSMEM 83..103
/note="Helical; Name=1"
/evidence="ECO:0000255"
TOPO_DOM 104..108
/note="Cytoplasmic"
/evidence="ECO:0000255"
TRANSMEM 109..129
/note="Helical; Name=2"
/evidence="ECO:0000255"
TOPO_DOM 130..151
/note="Extracellular"
/evidence="ECO:0000255"
TRANSMEM 152..172
/note="Helical; Name=3"
/evidence="ECO:0000255"
TOPO_DOM 173..192
/note="Cytoplasmic"
/evidence="ECO:0000255"
TRANSMEM 193..213
/note="Helical; Name=4"
/evidence="ECO:0000255"
TOPO_DOM 214..247
/note="Extracellular"
/evidence="ECO:0000255"
TRANSMEM 248..268
/note="Helical; Name=5"
/evidence="ECO:0000255"
TOPO_DOM 269..283
/note="Cytoplasmic"
/evidence="ECO:0000255"
TRANSMEM 284..304
/note="Helical; Name=6"
/evidence="ECO:0000255"
TOPO_DOM 305..319
/note="Extracellular"
/evidence="ECO:0000255"
TRANSMEM 320..343
/note="Helical; Name=7"
/evidence="ECO:0000255"
TOPO_DOM 344..385
/note="Cytoplasmic"
/evidence="ECO:0000255"
REGION 21..42
/note="Disordered"
/evidence="ECO:0000256|SAM:MobiDB-lite"
REGION 362..385
/note="Disordered"
/evidence="ECO:0000256|SAM:MobiDB-lite"
COMPBIAS 21..38
/note="Polar residues"
/evidence="ECO:0000256|SAM:MobiDB-lite"
SITE 47..48
/note="Cleavage; by thrombin or trypsin"
/evidence="ECO:0000250"
CARBOHYD 56
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
DISULFID 149..228
/evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
VARIANT 120
/note="A -> T (in dbSNP:rs773902)"
/evidence="ECO:0000269|PubMed:9618465,
ECO:0000269|PubMed:9716134, ECO:0000269|PubMed:9722561"
/id="VAR_028300"
VARIANT 215
/note="R -> Q (in dbSNP:rs2230799)"
/id="VAR_028301"
VARIANT 296
/note="F -> V (in dbSNP:rs2227346)"
/evidence="ECO:0000269|Ref.5"
/id="VAR_012852"
VARIANT 310
/note="P -> L (in dbSNP:rs2227376)"
/evidence="ECO:0000269|Ref.5"
/id="VAR_012853"
MUTAGEN 47
/note="R->A: No proteolytic cleavage (by thrombin or
trypsin)."
/evidence="ECO:0000269|PubMed:9618465"
MUTAGEN 68
/note="R->A: No effect on receptor activation."
/evidence="ECO:0000269|PubMed:9618465"
STRAND 44..46
/evidence="ECO:0007829|PDB:3QDZ"
SEQUENCE 385 AA; 41133 MW; FACE32F10D5C561E CRC64;
MWGRLLLWPL VLGFSLSGGT QTPSVYDESG STGGGDDSTP SILPAPRGYP GQVCANDSDT
LELPDSSRAL LLGWVPTRLV PALYGLVLVV GLPANGLALW VLATQAPRLP STMLLMNLAA
ADLLLALALP PRIAYHLRGQ RWPFGEAACR LATAALYGHM YGSVLLLAAV SLDRYLALVH
PLRARALRGR RLALGLCMAA WLMAAALALP LTLQRQTFRL ARSDRVLCHD ALPLDAQASH
WQPAFTCLAL LGCFLPLLAM LLCYGATLHT LAASGRRYGH ALRLTAVVLA SAVAFFVPSN
LLLLLHYSDP SPSAWGNLYG AYVPSLALST LNSCVDPFIY YYVSAEFRDK VRAGLFQRSP
GDTVASKASA EGGSRGMGTH SSLLQ